Novoprotein Scientific Statistics
Total Valuation
SHA:688137 has a market cap or net worth of CNY 3.60 billion. The enterprise value is 2.88 billion.
| Market Cap | 3.60B |
| Enterprise Value | 2.88B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688137 has 69.77 million shares outstanding. The number of shares has decreased by -0.43% in one year.
| Current Share Class | 69.77M |
| Shares Outstanding | 69.77M |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | +2.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 5.20% |
| Float | 26.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.97 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -37.62 |
| EV / Sales | 19.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -31.20 |
Financial Position
The company has a current ratio of 23.22, with a Debt / Equity ratio of 0.03.
| Current Ratio | 23.22 |
| Quick Ratio | 10.69 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.57 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -3.72% and return on invested capital (ROIC) is -4.68%.
| Return on Equity (ROE) | -3.72% |
| Return on Assets (ROA) | -1.80% |
| Return on Invested Capital (ROIC) | -4.68% |
| Return on Capital Employed (ROCE) | -3.03% |
| Weighted Average Cost of Capital (WACC) | 12.55% |
| Revenue Per Employee | 265,445 |
| Profits Per Employee | -135,299 |
| Employee Count | 556 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.66 |
Taxes
In the past 12 months, SHA:688137 has paid 10.57 million in taxes.
| Income Tax | 10.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.39% in the last 52 weeks. The beta is 1.54, so SHA:688137's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +55.39% |
| 50-Day Moving Average | 44.40 |
| 200-Day Moving Average | 43.78 |
| Relative Strength Index (RSI) | 61.45 |
| Average Volume (20 Days) | 1,206,425 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688137 had revenue of CNY 150.24 million and -76.58 million in losses. Loss per share was -1.09.
| Revenue | 150.24M |
| Gross Profit | 103.65M |
| Operating Income | -62.65M |
| Pretax Income | -66.01M |
| Net Income | -76.58M |
| EBITDA | -49.28M |
| EBIT | -62.65M |
| Loss Per Share | -1.09 |
Balance Sheet
The company has 772.94 million in cash and 52.55 million in debt, with a net cash position of 720.39 million or 10.33 per share.
| Cash & Cash Equivalents | 772.94M |
| Total Debt | 52.55M |
| Net Cash | 720.39M |
| Net Cash Per Share | 10.33 |
| Equity (Book Value) | 2.02B |
| Book Value Per Share | 28.59 |
| Working Capital | 1.76B |
Cash Flow
In the last 12 months, operating cash flow was -14.17 million and capital expenditures -78.17 million, giving a free cash flow of -92.34 million.
| Operating Cash Flow | -14.17M |
| Capital Expenditures | -78.17M |
| Depreciation & Amortization | 13.36M |
| Net Borrowing | n/a |
| Free Cash Flow | -92.34M |
| FCF Per Share | -1.32 |
Margins
Gross margin is 68.99%, with operating and profit margins of -41.70% and -50.97%.
| Gross Margin | 68.99% |
| Operating Margin | -41.70% |
| Pretax Margin | -43.94% |
| Profit Margin | -50.97% |
| EBITDA Margin | -32.80% |
| EBIT Margin | -41.70% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688137 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.43% |
| Shareholder Yield | 0.43% |
| Earnings Yield | -2.13% |
| FCF Yield | -2.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |